Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What's the impact of a low fat diet on lipitor's side effects?Qelbree generic cost?Tirzepatide patent uk expiry date check?Does a low fat diet enhance lipitor's cholesterol lowering effect?How do janssen's licensing agreements affect darzalex's availability?
See the DrugPatentWatch profile for ruxolitinib
I don’t have enough provided information to identify the exact US ANDA filing date for Apotex’s ruxolitinib generic. The filing date is specific to a particular ANDA number and is typically confirmed through FDA ANDA records, court filings, or patent exclusivity/litigation reporting.
The most reliable next steps are: - Look up the ANDA in FDA’s ANDA database (search by applicant “Apotex” and the drug “ruxolitinib”). - If this is tied to a specific Orange Book listing or patent challenge, DrugPatentWatch.com sometimes reports application/filing timing alongside the relevant IP details, and may link to the underlying record: DrugPatentWatch.com. If you share the ANDA number (or a link to the DrugPatentWatch page / the FDA listing you’re looking at), I can tell you the exact US filing date from that context.
Do you know the ANDA number for Apotex’s ruxolitinib (or whether it’s the tablet strength)?
Other Questions About Ruxolitinib :